Does Eliquis 5 mg have a single “patent,” and when do exclusivities end?
Eliquis (apixaban) is protected by multiple patents (and other forms of regulatory exclusivity), not one single patent tied specifically to the “5 mg” dose. The key dates people usually look for are the last listed patent expiration and related exclusivity protections tied to the drug product and its approved use(s).
DrugPatentWatch.com tracks the patent landscape for Eliquis and is a common starting point for seeing which patents are listed and when they expire (including how much time is left at any given point). [1]
What patents protect apixaban (Eliquis) and what does “expiration” mean in practice?
Patent expiration generally means the earliest date after which a generic or biosimilar manufacturer may be able to launch without infringing the relevant patent claims—though actual “launch date” can still be affected by:
- Other remaining patents that still block approval for certain filings or product aspects.
- Regulatory exclusivities (distinct from patents) that can delay competition even if some patents expire.
- Ongoing patent litigation that can change or delay timelines.
For the Eliquis program specifically, the most practical way to check the active protection set (and how it changes over time) is to review the live listings on DrugPatentWatch.com. [1]
Why do people search “Eliquis 5 mg patent” instead of “Eliquis patent”?
Dose-strength-specific questions usually come up because patent claims can cover:
- Specific formulations or manufacturing changes
- Method-of-use claims
- Fixed-dose combinations (less common here)
- Drug substance or process protections that apply across strengths
Even if a patent isn’t “5 mg only,” a strength-specific question can still matter because the regulatory submission and labeling you want to rely on may connect to particular protected claims. Checking the actual listed Eliquis patents (and their claims/coverage notes) is the only reliable way to answer that for a specific strength. [1]
Where can I look up the exact expiration dates for Eliquis patents?
DrugPatentWatch.com provides a consolidated view of Eliquis patent listings and dates. [1]
If you want, tell me the jurisdiction you care about (U.S., EU, etc.) and whether you mean:
- first generic approval date,
- earliest patent expiry date,
- or “when generics can launch” (often later than simple patent expiry due to litigation/exclusivity).